| dc.contributor.author | Hashem, S | en_US |
| dc.contributor.author | Davies, WG | en_US |
| dc.contributor.author | Fornili, A | en_US |
| dc.date.accessioned | 2020-12-18T11:39:01Z | |
| dc.date.available | 2020-11-19 | en_US |
| dc.date.issued | 2020 | en_US |
| dc.identifier.issn | 1549-9596 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/69421 | |
| dc.format.extent | 6438 - 6446 | en_US |
| dc.relation.ispartof | JOURNAL OF CHEMICAL INFORMATION AND MODELING | en_US |
| dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Chemical Information and Modeling following peer review. The version of record is available https://pubs.acs.org/doi/10.1021/acs.jcim.0c00953 | |
| dc.title | Heart Failure Drug Modifies the Intrinsic Dynamics of the Pre-Power Stroke State of Cardiac Myosin | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2020 American Chemical Society | |
| dc.identifier.doi | 10.1021/acs.jcim.0c00953 | en_US |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000608875100078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 12 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 60 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| qmul.funder | Modelling of cardiac myosin activators for the design of cardiovascular drugs::Royal Society of Chemistry | en_US |
